Status:
COMPLETED
Human Papillomavirus Epidemiology in Nigeria
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Human Papillomavirus 18
Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
30-49 years
Phase:
NA
Brief Summary
Background: * Cervical cancer is caused by persistent infection of the lining of the cervix with some kinds of human papillomaviruses (HPV). These HPV infections are distantly related to the viruses ...
Detailed Description
BACKGROUND: Cervical cancer, caused by persistent infection with approximately 15-20 genotypes of carcinogenic human papillomavirus (HPV) infection, is the second leading cause of female cancer. Cytol...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Females who are 15 years to 99 years of age
- EXCLUSION CRITERIA:
- Previous hysterectomy
- Current pregnancy
- Inability to give informed consent
Exclusion
Key Trial Info
Start Date :
July 6 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2020
Estimated Enrollment :
1466 Patients enrolled
Trial Details
Trial ID
NCT00804466
Start Date
July 6 2009
End Date
November 10 2020
Last Update
November 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obafemi Awolowo University Teaching Hospital
Ile-Ife, Nigeria